The Trump administration has finalized a deal with drugmaker AbbVie to cut the cost of certain medicines, marking the latest pact as part of its "Most Favored Nation" pricing initiative.

While researchers caution it's not a "one-size-fits-all solution," the news could be helpful for certain Americans.

The Supreme Court is reviewing two cases from Idaho and West Virginia that will impact transgender athletes in women's sports ...

Overall, they estimated that a “combined dose” of increasing sleep by five minutes per day, just two minutes more of ...

The announcements reflect a calculated shift from discrete chip sales to integrated systems that address enterprise ...

Major stock indexes ended lower Tuesday, a day after the S&P 500 and Dow Jones Industrial Average set fresh records, as investors digested a consumer inflation reading that matched expectations and ...

The Jan. 3 snapshot, though incomplete, indicates a stabler marketplace and less coverage loss than many experts and insurers feared.

Four Corners Property Trust, Inc. is rated a Buy due to sustainable dividend, solid financials and attractive valuation. Read ...

New-home sales volumes mask a harsh truth: builders are cutting prices, raising incentives, and absorbing losses amidst federal housing policy chaos.

RFK Jr.'s 2025–2030 dietary guidelines include a new inverted food pyramid. Experts have mixed reactions to these changes, ...

After cutting interest rates three times in a row last year, the Federal Reserve indicated last month it probably won’t lower interest rates again for a while. A months-long pause, cemented by key ...

Discover how companies boost profits through first, second, and third-degree price discrimination strategies, targeting ...